Covid19 Pneumonia

11 registered clinical trials studyying Covid19 Pneumonia.

Status	Trial	Sponsor	Phase
Unknown	Study to Evaluate the Efficacy and Safety of AstroStem-V in Treatment of COVID-19 Pneumonia NCT04527224	Nature Cell Co. Ltd.	Phase 1 / Phase 2
Unknown	Prevention of COVID-19 Infection to Severe Pneumonia or ARDS NCT04569227	Enzychem Lifesciences Corporation	Phase 2
Completed	Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients NCT04565379	Shaperon	Phase 2
Unknown	N-terminal Pro B-type Natriuretic Peptide and Vitamin D Levels as Prognostic Markers in COVID-19 Pneumonia NCT04487951	Cairo University	—
Unknown	COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Progr NCT04881214	University Hospital, Geneva	N/A
Unknown	Effectiveness of Pulmonary Rehabilitation Program in Patients With SARS-CoV-2 Pneumonia NCT04642040	Sisli Hamidiye Etfal Training and Research Hospital	N/A
Unknown	Trial Evaluating Efficacy and Safety of Anticoagulation in Patients With COVID-19 Infection, Nested in the Cor NCT04344756	Assistance Publique - Hôpitaux de Paris	Phase 2
Completed	Convalescent Plasma as Potential Therapy for Severe COVID-19 Pneumonia NCT04535063	Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno	Phase 3
Unknown	Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, N NCT04344782	Assistance Publique - Hôpitaux de Paris	Phase 2
Unknown	The Use of Tocilizumab in the Management of Patients Who Have Severe COVID-19 With Suspected Pulmonary Hyperin NCT04377750	Hadassah Medical Organization	Phase 4
Completed	Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT NCT03183570	Stanford University	EARLY_Phase 1